Lactiplantibacillus plantarum NMGL2 exopolysaccharide ameliorates DSS-induced IBD in mice mainly by regulation of intestinal tight junction and NF-κB p65 protein expression

Treatment of inflammatory bowel disease (IBD), a common chronic intestinal disease, by exopolysaccharides (EPSs) produced by lactic acid bacteria has raised increasing concerns. Here, the EPS produced by Lactiplantibacillus plantarum NMGL2 was evaluated for its ameliorating effect on dextran sodium...

Full description

Bibliographic Details

Published in:	Frontiers in Microbiology
Main Authors:	Zengjia Zhou, Min Zhang, Mengke Yao, Jasra Naseeb, Abid Sarwar, Zhennai Yang, Tariq Aziz, Majid Alhomrani, Walaa F. Alsanie, Abdulhakeem S. Alamri
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-10-01
Subjects:	dextran sulfate sodium Lactiplantibacillus plantarum inflammatory bowel disease exopolysaccharide NF-κB
Online Access:	https://www.frontiersin.org/articles/10.3389/fmicb.2024.1491727/full